Array Technologies (ARRY)
(Delayed Data from NSDQ)
$12.40 USD
+0.46 (3.85%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $12.41 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Brokerage Reports
0 items in cart
Array Technologies, Inc. [ARRY]
Reports for Purchase
Showing records 481 - 500 ( 512 total )
Company: Array Technologies, Inc.
Industry: Solar
Company: Array Technologies, Inc.
Industry: Solar
The Solar Snapshot: Resi Solar Backlogs Likely Growing Ahead; DC Update
Provider: Roth Capital Partners, Inc.
Analyst: SHEN P
Company: Array Technologies, Inc.
Industry: Solar
Company: Array Technologies, Inc.
Industry: Solar
Initiating at Buy on Strong Growth and Industry Position
Provider: Roth Capital Partners, Inc.
Analyst: SHEN P
Company: Array Technologies, Inc.
Industry: Solar
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
We are placing Array BioPharma Under Review due to the departure from the firm of analyst, Simos Simeonidis
Provider: RODMAN & RENSHAW, CO.
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
We are placing Array BioPharma Under Review due to the departure from the firm of analyst, Simos Simeonidis
Provider: RODMAN & RENSHAW, CO.
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Reports 2Q11 numbers; waiting for selumetinib (MEK inhibitor) data this year
Provider: RODMAN & RENSHAW, CO.
Analyst: SIMEONIDIS S
Company: Array Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Reports 2Q11 numbers; waiting for selumetinib (MEK inhibitor) data this year
Provider: RODMAN & RENSHAW, CO.
Analyst: SIMEONIDIS S